Literature DB >> 34030963

Impact of the Natural Compound Urolithin A on Health, Disease, and Aging.

Davide D'Amico1, Pénélope A Andreux2, Pamela Valdés2, Anurag Singh2, Chris Rinsch2, Johan Auwerx3.   

Abstract

Urolithin A (UA) is a natural compound produced by gut bacteria from ingested ellagitannins (ETs) and ellagic acid (EA), complex polyphenols abundant in foods such as pomegranate, berries, and nuts. UA was discovered 40 years ago, but only recently has its impact on aging and disease been explored. UA enhances cellular health by increasing mitophagy and mitochondrial function and reducing detrimental inflammation. Several preclinical studies show how UA protects against aging and age-related conditions affecting muscle, brain, joints, and other organs. In humans, benefits of UA supplementation in the muscle are supported by recent clinical trials in elderly people. Here, we review the state of the art of UA's biology and its translational potential as a nutritional intervention in humans.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  aging; inflammation; mitochondria; mitophagy; muscle health; urolithin A

Mesh:

Substances:

Year:  2021        PMID: 34030963     DOI: 10.1016/j.molmed.2021.04.009

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  32 in total

1.  Urolithin A attenuates arsenic-induced gut barrier dysfunction.

Authors:  Sweta Ghosh; Mayukh Banerjee; Bodduluri Haribabu; Venkatakrishna Rao Jala
Journal:  Arch Toxicol       Date:  2022-02-05       Impact factor: 5.153

Review 2.  Impact of nutraceuticals and dietary supplements on mitochondria modifications in healthy aging: a systematic review of randomized controlled trials.

Authors:  Lorenzo Lippi; Francesca Uberti; Arianna Folli; Alessio Turco; Claudio Curci; Francesco d'Abrosca; Alessandro de Sire; Marco Invernizzi
Journal:  Aging Clin Exp Res       Date:  2022-08-03       Impact factor: 4.481

3.  Conjugates of urolithin A with NSAIDs, their stability, cytotoxicity, and anti-inflammatory potential.

Authors:  Maciej Korczak; Piotr Roszkowski; Sebastian Granica; Jakub P Piwowarski
Journal:  Sci Rep       Date:  2022-07-08       Impact factor: 4.996

Review 4.  Recent Advances and Perspectives on the Health Benefits of Urolithin B, A Bioactive Natural Product Derived From Ellagitannins.

Authors:  Peng Chen; Zhiei Guo; Fuchao Chen; Yue Wu; Benhong Zhou
Journal:  Front Pharmacol       Date:  2022-06-22       Impact factor: 5.988

5.  Combinatory Exposure to Urolithin A, Alternariol, and Deoxynivalenol Affects Colon Cancer Metabolism and Epithelial Barrier Integrity in vitro.

Authors:  Julia Groestlinger; Carina Seidl; Elisabeth Varga; Giorgia Del Favero; Doris Marko
Journal:  Front Nutr       Date:  2022-06-24

Review 6.  Autophagy and the hallmarks of aging.

Authors:  Susmita Kaushik; Inmaculada Tasset; Esperanza Arias; Olatz Pampliega; Esther Wong; Marta Martinez-Vicente; Ana Maria Cuervo
Journal:  Ageing Res Rev       Date:  2021-09-24       Impact factor: 10.895

7.  Protective effects of mitophagy enhancers against amyloid beta-induced mitochondrial and synaptic toxicities in Alzheimer disease.

Authors:  Sudhir Kshirsagar; Neha Sawant; Hallie Morton; Arubala P Reddy; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2022-02-03       Impact factor: 5.121

Review 8.  The blood-brain barrier in aging and neurodegeneration.

Authors:  Emily G Knox; Maria R Aburto; Gerard Clarke; John F Cryan; Caitriona M O'Driscoll
Journal:  Mol Psychiatry       Date:  2022-03-31       Impact factor: 13.437

Review 9.  Pomegranate (Punica granatum L.) and Metabolic Syndrome Risk Factors and Outcomes: A Systematic Review of Clinical Studies.

Authors:  Lucas Fornari Laurindo; Sandra Maria Barbalho; Alexis R Marquess; Annik Ianara de Souza Grecco; Ricardo de Alvares Goulart; Ricardo José Tofano; Anupam Bishayee
Journal:  Nutrients       Date:  2022-04-16       Impact factor: 6.706

Review 10.  Microbial Metabolites in Multiple Sclerosis: Implications for Pathogenesis and Treatment.

Authors:  Eduardo Duarte-Silva; Sven G Meuth; Christina Alves Peixoto
Journal:  Front Neurosci       Date:  2022-04-28       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.